A Study of RM-718 in Healthy Subjects and in Patients With HO
Status:
RECRUITING
Trial end date:
2026-05-04
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, and PK of RM-718 in healthy subjects with obesity and in patients with hypothalamic obesity (HO).